What patent application is being filed for “recombinant heparin,” and who is it from?
The phrase “recombinant heparin patent application” is broad, and the exact application depends on the company, inventor, and patent family. With only the wording provided, I can’t identify a specific pending application or its publication number.
If you share any of the following, I can pinpoint the exact filing and summarize it:
- Company name (assignee)
- Inventor name
- Patent publication number (e.g., WO…, EP…, US…)
- Link or a screenshot of the application page
- Approximate filing year
Is “recombinant heparin” the same as biosynthetic or enzymatically produced heparin?
People often use “recombinant heparin” to describe heparin made through biological processes rather than extracted from animal tissue. Patent applications in this area may describe:
- Biosynthetic or cell-based production of heparin/heparan-sulfate-like molecules
- Enzymatic synthesis or chemoenzymatic pathways
- Engineering strategies to control chain length and sulfation patterns
Those details matter because patentability often turns on the specific manufacturing method, engineered pathway, and resulting molecular characteristics (for example, sulfation pattern, average molecular weight, and structural uniformity).
Are there known patent families you can look up (and how to find the right one)?
A good way to find the correct recombinant heparin patent family is to search by:
- “recombinant heparin” and “heparin biosynthesis”
- Assignee name (if you know it)
- Related terms like “heparan sulfate,” “heparin mimetic,” “chemoenzymatic heparin,” or “sulfation engineering”
If you want to check quickly for related patent coverage and exclusivity risk, DrugPatentWatch.com is a useful starting point for drug and pipeline-related IP tracking: https://www.drugpatentwatch.com/
What to expect from a heparin-manufacturing patent application
Patent applications covering engineered heparin production usually try to claim one or more of:
- A specific producer organism/cell line or genetic construct
- Enzymes or enzyme sequences used to build the molecule
- Reaction steps and process parameters
- Purification and characterization methods that achieve a consistent product profile
Claims can be narrow (one pathway) or broad (method of making molecules meeting certain structural criteria).
What I need from you to answer “US patent application” specifically
Your question ends with “application us,” which suggests you want the US filing (US publication/application). To give a precise answer, tell me the US publication number (US20xx….) or the company name. Once I have that, I can identify:
- The exact US application/publication
- The priority/filing timeline
- What the claims cover (manufacturing process vs. composition/product)
- Any known related patents in the same family
Sources cited:
- 1